Corey S. Goodman - 02 Feb 2026 Form 4 Insider Report for ALX ONCOLOGY HOLDINGS INC (ALXO)

Role: Director, 10%+ Owner
Signature: /s/ Shelly Pinto, by power of attorney
Issuer symbol: ALXO
Transactions as of: 02 Feb 2026
Net transactions value: +$4,999,999
Form type: 4
Filing time: 04 Feb 2026, 16:15:59 UTC
Previous filing: 21 Jan 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
GOODMAN COREY S	Director, 10%+ Owner	C/O VENBIO PARTNERS, LLC, 1700 OWENS STREET, SUITE 595, SAN FRANCISCO	/s/ Shelly Pinto, by power of attorney	04 Feb 2026	0001278411

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ALXO	Common Stock	Purchase	$4,999,999	+3,184,713	+60%	$1.57	8,453,038	02 Feb 2026	See footnote	F1
holding	ALXO	Common Stock						3,969,789	02 Feb 2026	See footnote	F2
holding	ALXO	Common Stock						461,811	02 Feb 2026	See footnote	F3
holding	ALXO	Common Stock						113,287	02 Feb 2026	See footnote	F4
holding	ALXO	Common Stock						54,083	02 Feb 2026	See footnote	F5

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares are held of record by venBio Global Strategic Fund II, L.P. venBio Global Strategic GP II, LP is the sole general partner of venBio Global Strategic Fund II, LP and venBio Global Strategic GP II, Ltd. is the sole general partner of venBio Global Strategic GP II, L.P. The reporting person, a director of venBio Global Strategic GP II, Ltd., disclaims beneficial ownership of such securities, except to the extent of his indirect pecuniary interest therein.
F2	The shares are held of record by venBio Global Strategic Fund, L.P. venBio Global Strategic GP, L.P. is the general partner of venBio Global Strategic Fund, L.P. and venBio Global Strategic GP, Ltd. is the general partner of venBio Global Strategic GP, L.P. The reporting person, a director of venBio Global Strategic GP, Ltd., disclaims beneficial ownership of such securities, except to the extent of his indirect pecuniary interest therein.
F3	The shares are held of record by venBio SPV, LLC, which is wholly-owned by venBio Global Strategic Fund, L.P. The reporting person, a managing director of venBio SPV, LLC, disclaims beneficial ownership of such securities, except to the extent of his indirect pecuniary interest therein.
F4	The shares are held of record by the Goodman Barinaga Trust for which the reporting person serves as trustee.
F5	The shares are held of record by Emaldi Corporation for which the reporting person serves as a director. The reporting person disclaims beneficial ownership of such securities, except to the extent of his indirect pecuniary interest therein.